Prellis Biologics

Prellis Biologics

Focus:

Type: Startup
Founded: 2016


Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation.

Leadership
Melanie Matheu
Founder
Past Roles
Associate Director, Immunology (Adheren)

Noelle Mullin
Founder
Past Roles
Senior Scientist (Pfizer CTI)


Funding


Raised Capital
Year
Type
Offered / Sold Amount
Filings
Reported by Press*
Round
2019
8.7M USD
Series A
2017
1.87M USD
Seed
Known Investors
Name
Type
HQ
Other Relevant Investments
Venture Capital
United States
Venture Capital
United States
Accelerator
United States
Venture Capital
United States
Accelerator
United States
Venture Capital
United States
Venture Capital
United States
*More data available at: [CB Insights] [CrunchBase] [PitchBook]

News